Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone-choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women

IUBMB Life

Volumn 68, Issue 1, 2016, Pages 23-36

  El Shal, Amal S ^a   Zidan, Haidy E ^a   Rashad, Nearmeen M ^a   Abdelaziz, Ahmed M ^b   Harira, Mervat M ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b BENHA UNIVERSITY   (Egypt)

Author keywords

Egyptian women; luteinizing hormone; obesity; polycystic ovary syndrome; polymerase chain reaction

Indexed keywords

LUTEINIZING HORMONE; LUTEINIZING HORMONE BETA SUBUNIT; LUTEINIZING HORMONE RECEPTOR;

ADULT; ALLELE; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; EGYPTIAN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION; CASE CONTROL STUDY; EGYPT; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; EGYPT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUTEINIZING HORMONE, BETA SUBUNIT; MUTAGENESIS, INSERTIONAL; OBESITY; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LH;

EID: 84955171199     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1457     Document Type: Article

References (59)

1. Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., and, Azziz, R., (2011) Polycystic ovary syndrome. Etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 7, 219-231.
2. Brassard, M., AinMelk, Y., and, Baillargeon, J. P., (2008) Basic infertility including polycystic ovary syndrome. Med. Clin. North Am. 92, 1163-1192.
3. Teede, H., Deeks, A., and, Moran, L., (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impact on health across the lifespan. BMC Med. 30, 41.
4. Mahmoudi, T., (2009) Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil. Steril. 92, 1381-1383.
5. Hahn, S., Haselhorst, U., Tan, S., Quadbeck, B., Schmidt, M., et al., (2006) Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp. Clin. Endocrinol. Diabetes 114, 577-583.
6. Almawi, W. Y., Hubail, B., Arekat, D. Z., Al-Farsi, S. M., Al-Kindi, S. K., et al., (2015) Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome. J. Assist. Reprod. Genet. 32, 607-614.
7. Liu, N., Ma, Y., Wang, S., Zhang, X., Zhang, Q., et al., (2012) Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome. Reprod. Biol. Endocrinol. 10, 36-42.
8. Themmen, A. P., (2005) An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 130, 263-274.
9. Mutharasan, P., Galdones, E., Peñalver Bernabé, B., Garcia, O. A., Jafari, N., et al., (2013) Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J. Clin. Endocrinol. Metab. 98, 185-190.
10. Fiddes, J. C., and, Talmadge, K., (1984) Structure, expression, and evolution of the genes for the human glycoprotein hormones. Rec. Prog. Horm. Res. 40, 43-78.
11. Dufau, M. L., (1998) The luteinizing hormone receptor. Annu. Rev. Physiol. 60, 461-496.
12. Ascoli, M., Fanelli, F., and, Segaloff, D. L., (2002) The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 23, 141-174.
13. Norman, R. J., Dewailly, D., Legro, R. S., and, Hickey, T. E., (2007) Polycystic ovary syndrome. Lancet 370, 685-697.
14. Balen, A. H., (1993) Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Hum. Reprod. 8, 123-128.
15. Huhtaniemi, I., and, Alevizaki, M., (2006) Gonadotrophin resistance. Best Pract. Res. Clin. Endocrinol. Metab. 20, 561-576.
16. Huhtaniemi, I. T., and, Themmen, A. P., (2005) Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 26, 207-217.
17. Ha, L., Shi, Y., Zhao, J., Li, T., and, Chen, Z.-J., (2015) Association study between polycystic ovarian syndrome and the susceptibility genes polymorphisms in Hui Chinese women. Plos One 10, e0126505.
18. Ramanujam, L. N., Liao, W. X., Roy, A. C., Loganath, A., Goh, H. H., et al., (1999) Association of molecular variants of luteinizing hormone with menstrual disorders. Clin. Endocrinol. (Oxf.) 51, 243-246.
19. Dos Santos, E., Dieudonne, M. N., Leneveu, M. C., Pecquery, R., Serazin, V., et al., (2007) In vitro effects of chorionic gonadotropin hormone on human adipose development. J. Endocrinol. 194, 313-325.
20. Nelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., et al., (2005) Alterations in mitogen-activated protein kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol. Endocrinol. 19, 379-390.
21. Piersma, D., Berns, E. M., Verhoef-Post, M., Uitterlinden, A. G., Braakman, I., et al., (2006) A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. J. Clin. Endocrinol. Metab. 91, 1470-1476.
22. Bhowmick, N., Huang, J., Puett, D., Isaacs, N. W., and, Lapthorn, A. J., (1996) Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol. Endocrinol. 10, 1147-1159.
23. Bassiouny, Y. A., Rabie, W. A., Hassan, A. A., and, Darwish, R. K., (2014) Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome. Gynecol. Endocrinol. 30, 428-430.
24. The Rotterdam ESHRE-ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41-47.
25. National Institutes of Health Consensus Development Panel (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes. Res. 6, 51-209.
26. Friedewald, W. T., Levy, R. I., and, Fredrickson, D. S., (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502.
27. Matthews, D. R., Hosker, J. P., Rudenski, A. S., et al., (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
28. Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., et al., (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85, 2402-2410.
29. Al Kindi, M. K., Al Essry, F. S., Al Essry, F. S., and, Mula-Abed, W. A., (2012) Validity of serum testosterone, free androgen index, and calculated free testosterone in women with suspected hyperandrogenism. Oman Med. J. 27, 471-474.
30. Lee, S., Kim, N. K., Kim, H. J., Lee, S. H., Jeong, H. J., et al., (2003) Genetic analysis of three polymorphic sites of the luteinizing hormone β-subunit gene in infertile Korean men with nonobstructive azoospermia. Fertil. Steril. 79, 517-521.
31. Capalbo, A., Sagnella, F., Apa, R., Fulghesu, A. M., Lanzone, A., et al., (2012) The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2.7-fold increased risk of polycystic ovary syndrome in a Sardinian population. Clin. Endocrinol. (Oxf.) 77, 113-119.
32. Gordon, D., Haynes, C., Blumenfeld, J., and, Finch, S. J., (2005) PAWE-3D: visualizing power for association with error in case/control genetic studies of complex traits. Bioinformatics 21, 3935-3937.
33. Wijeyaratne, C. N., Seneviratne Rde, A., Dahanayake, S., Kumarapeli, V., Palipane, E., et al., (2011) Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum. Reprod. 26, 202-213.
34. Wild, R. A., Rizzo, M., Clifton, S., and, Carmina, E. (, 2011) Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil. Steril. 95, 1073-9.e1-1073-9.e11.
35. Phelan, N., O'Connor, A., Kyaw-Tun, T., Correia, N., Boran, G., et al., (2010) Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS. J. Clin. Endocrinol. Metab. 95, 3933-3939.
36. Fulghesu, A., Magnini, R., Portoghese, E., Angioni, S., Minerba, L., et al., (2010) Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome. J. Adolesc. Health 46, 474-481.
37. Hashad, D., Mohamed, N., and, Hashad, M. M., (2012) Luteinising hormone β-subunit gene Gly102Ser variant and oxidative stress biomarkers in Egyptian infertile males. Andrologia 44, 484-489.
38. Kim, N. K., Nam, Y. S., Ko, J. J., Chung, H. M., Chung, K. W., et al., (2001) The luteinizing hormone β-subunit exon 3 (Gly102Ser) gene mutation is rare in Korean women with endometriosis and polycystic ovary syndrome. Fertil. Steril. 75, 1238-1239.
39. Ramanujam, L., Liao, W. X., Roy, A. C., Ng, S. C., and, Ratnam, S. S., (1998) Molecular variants of luteinizing hormone in three populations of Southeast Asia. Hum. Hered. 48, 232-234.
40. Laven, J. S., Imani, B., Eijkemans, M. J., and, Fauser, B. C., (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet. Gynecol. Surv. 57, 755-767.
41. Valkenburg, O., Uitterlinden, A. G., Piersma, D., Hofman, A., Themmen, A. P., et al., (2009) Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum. Reprod. 24, 2014-2022.
42. Thathapudi, S., Kodati, V., Erukkambattu, J., Addepally, U., and, Qurratulain, H., (2015) Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genet. Test. Mol. Biomarkers, 19, 128-132.
43. Lindeberg, M., Carlström, K., Ritvos, O., and, Hovatta, O., (2007) Gonadotrophin stimulation of non-luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis. Hum. Reprod. 22, 401-406.
44. Sasson, R., Rimon, E., Dantes, A., Cohen, T., Shinder, V., et al., (2004) Gonadotrophin-induced gene regulation in human granulosa cells obtained from IVF patients. Modulation of steroidogenic genes, cytoskeletal genes and genes coding for apoptotic signaling and protein kinases. Mol. Hum. Reprod. 10, 299-311.
45. Jakimiuk, A. J., Weitsman, S. R., Navab, A., and, Magoffin, D. A., (2001) Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 86, 1318-1323.
46. Willis, D. S., Watson, H., Mason, H. D., Galea, R., Brincat, M., et al., (1998) Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J. Clin. Endocrinol. Metab. 83, 3984-3991.
47. Suganuma, N., Furui, K., and, Furuhashi, M., (1995) Screening of the mutations in luteinizing hormone β-subunit in patients with menstrual disorders. Fertil. Steril. 336, 673-675.
48. Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U., and, Pasquali, R., (2002) Obesity and the polycystic ovary syndrome. Int. J. Obes. Relat. Metab. Disord. 26, 883-896.
49. Ezeh, U., Yildiz, B. O., and, Azziz, R., (2013) Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 98, E1088-E1096.
50. Polotsky, A. J., Allshouse, A. A., Casson, P. R., Coutifaris, C., Diamond, M. P., et al., (2015) Impact of male and female weight, smoking, and intercourse frequency on live birth in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 100, 2405-2412.
51. Pasquali, R., Casimirri, F., and, Vicennati, V., (1997) Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. Hum. Reprod. 12, 82-87.
52. Xita, N., and, Tsatsoulis, A., (2006) Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J. Clin. Endocrinol. Metab. 91, 1660-1666.
53. Baldani, D. P., Skrgatic, L., Goldstajn, M. S., Vrcic, H., Canic, T., et al., (2013) Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and non-obese women in the Croatian population. Coll. Antropol. 37, 465-470.
54. Sen, A., Prizant, H., Light, A., Biswas, A., Hayes, E., et al., (2014) Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. Proc. Natl. Acad. Sci. USA 111, 3008-3013.
55. Haavisto, A. M., Pettersson, K., Bergendahl, M., Virkamäki, A., and, Huhtaniemi, I., (1995) Occurrence and biological properties of a common genetic variant of luteinizing hormone. J. Clin. Endocrinol. Metab. 80, 1257-1263.
56. Wide, L., Eriksson, K., Sluss, P. M., and, Hall, J. E., (2010) The common genetic variant of luteinizing hormone has a longer serum half-life than the wild type in heterozygous women. J. Clin. Endocrinol. Metab. 95, 383-389.
57. Lamminen, T., Jiang, M., Manna, P. R., Pakarinen, P., Simonsen, H., et al., (2002) Functional study of a recombinant form of human LHβ subunit variant carrying the Gly(102)Ser mutation found in Asian populations. Mol. Hum. Reprod. 8, 887-892.
58. Segaloff, D. L., (2009) Diseases associated with mutations of the human lutropin receptor. Prog. Mol. Biol. Transl. Sci. 89, 97-114.
59. Ma, C. S., Lin, Y., Zhang, C. H., Xu, H., Li, Y. F., et al., (2011) Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary. Zhonghua Fu Chan Ke Za Zhi 46, 177-180.